By combining proprietary knowledge of dendritic cell behavior
and enabling presentation of relevant antigens via RNA, Argos’ vaccine
therapies unlock the potential of an individual’s own body, retraining
the immune system to recognize and target disease at its cellular origin.
Our technology has strong application for cancer and other clinical challenges,
including infectious disease, autoimmune disorders and transplantation.